FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Right Issue Status: Closed [17th Jul 2023 to 26th Jul 2023]
Eiko Lifesciences Limited offers Right Issue size of 5,544,178 equity shares worth of Rs 24.95 Cr. The subscription for this issue is opening from 17 July 2023 to 26 July 2023. The company issues 2 Rights equity shares for every fully paid-up 3 equity shares held on the record date of 07 July 2023. The face value of a share is Rs. 10 per share and the right issue price is fixed at Rs. 45 per share.
Stay updated with us to know more about the Eiko Lifesciences Limited Right Issue Details 2023 including issue size, right issue entitlement, terms of payment, and more.
The Company proposes to utilize the net proceeds from the Issue towards funding the following objects:
Eiko Lifesciences Issue Details | Values |
---|---|
Category | RightIssue |
Right Issue Issue Size (Shares) | 0.55 Cr Shares |
Right Issue Issue Size (Amount) | ₹24.95 Cr |
Face Value | ₹10 Per Equity Share |
Right Issue - Issue Price | ₹45 per share |
Right Issue Record Date | 7th Jul 2023 |
Right Issue Entitlement | 2 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
Right Issue Terms of payment | The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs. 10.50) is to be paid on the Application. Balance to be paid in not more than two calls as determined by the Board. |
Listing At | BSE |
BSE Code | 540204 |
NSE Code |
In this section we have covered all important dates related to Eiko Lifesciences Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
Right Issue Activity | Date |
---|---|
Right Issue Issue Open Date | 17th Jul 2023 |
Right Issue Issue Close Date | 26th Jul 2023 |
Basis of Allotment Finalisation Date* | 3rd Aug 2023 |
Refunds Initiation* | 20th Jul 2023 |
Credit of Shares to Demat Account* | 4th Aug 2023 |
Right Issue Listing Date* | 10th Aug 2023 |
* - Tentative Dates
Zerodha Trade@20
Eiko Lifesciences Limited was originally founded on January 07, 1977. This company is a manufacturer, supplier and exporter of specialty chemicals, fine chemicals, pharmaceutical intermediates, etc. The company is successfully engaged in manufacturing, processing, formulating, producing, purchasing, selling and exporting speciality and fine chemicals. The company's products are used in a wide range of agrochemicals, personal care products and food industries.
The company commenced commercial production in October 2020 at its manufacturing facility in Badlapur, Maharashtra. Since then, the company has expanded its operations, grown its brand and customer base, and become one of the fastest growing specialty chemical companies in India. Key products manufactured by this company are used in the pharmaceutical and agrochemical industries for various end-use applications, including anticorrosives, photo chemicals, solvents and corrosion inhibitors, to name a few.
The company's research and development centre not only works to develop new products, but also focuses on continuously improving processes to increase quality and reduce costs. Cost reduction is achieved by improving process efficiency, using innovative catalysts and saving on operating materials and energy costs.
Past performance and financial results of Eiko Lifesciences .
Period Ended | Total Assets | Total Revenue | Profit After Tax |
---|---|---|---|
31-Mar-21 | 16.61 | 12.45 | 0.61 |
31-Mar-22 | 34.89 | 26.09 | 0.71 |
Amount in ₹ Crore |
The table below is live update of Right Issue bidding details from NSE and BSE.
Eiko Lifesciences Right Issue Offer Document (Letter of Offer) >>Document
Eiko Lifesciences Right Issue Offer Document (Letter of Offer) >>Eiko Lifesciences Right Issue Red Herring Prospectus is not yet available.
Eiko Lifesciences Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Eiko Lifesciences Right Issue Online Application (Registrar & Transfer Agent) >>Eiko Lifesciences Right Issue RTA information is not yet available.
Last Updated on 2023-07-29T06:00:21+00:00